Medicare Part B reimbursement for physician-administered drugs is projected to rise from $18.7 billion in 2020 to $21.7 billion this year, and then to more than double to $46.2 billion by 2030, the Medicare Board of Trustees reported to Congress Tuesday.
In their Aug. 31 report, the Medicare trustees did not explain why they predict Part B payment for physician-administered drugs will rise so sharply in the coming decade. They said only that per-capita charges for the combined category of physician-administered drugs, durable medical equipment, laboratory services, and other practitioner services have grown due to factors including “increased number of services provided, demographic change, more expensive services, and certain administrative actions.”
Medicare Part B reimbursement for physician-administered drugs is projected to rise from $18.7 billion in 2020 to $21.7 billion this year, and then to more than double to $46.2 billion by 2030, the Medicare Board of Trustees reported to Congress Tuesday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
